Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1286-1293
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szczeklik, A.
Right arrow Articles by Jankowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szczeklik, A.
Right arrow Articles by Jankowski, M.

Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia

Andrzej Szczeklik, MD, PhDa, Jacek Musial, MD, PhDa, Anetta Undas, MDa, Piotr Gajewski, MDa, Pawel Góra, PhDa, Jakub Swadzba, MDa and Milosz Jankowski, MDa

a Departments of Medicine and Physics, School of Medicine, Jagiellonian University, Cracow, Poland



View larger version (43K):

[in a new window]
 
Figure 1 Thrombin generation as a function of time, c(t). co denotes the initial thrombin generation, {lambda} determines the rate of increase of the curve and S denotes the total amount of thrombin generated in the first 180 s, reflected by the shaded area under the curve.

 


View larger version (10K):

[in a new window]
 
Figure 2 Thrombin generation expressed as concentrations of prothrombin fragment 1+2 (F1+2) as a function of time, at baseline and after phase I, II and III.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement